A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma.
about
Evolution of management in peritoneal surface malignanciesTreatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectivesCytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review-past, present and futureRepeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: review of indications and outcomesCytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer and other less common disease histologies: is it time?Multimodality treatment strategies have changed prognosis of peritoneal metastasesClosed abdomen hyperthermic intraperitoneal chemotherapy with irinotecan and mitomycin C: a phase I study.Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancy.Malignant peritoneal mesothelioma with lymph node metastasis that originated in the transverse colon.Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysisAggressive locoregional surgical therapy for gastric peritoneal carcinomatosis.Advances in the management of peritoneal mesotheliomaEarly and long-term postoperative management following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Hyperthermic intraperitoneal chemotherapy: Rationale and techniqueMesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.Activity ex vivo of cytotoxic drugs in patient samples of peritoneal carcinomatosis with special focus on colorectal cancer.Gastrointestinal complications in 147 consecutive patients with peritoneal surface malignancy treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy.Appendiceal goblet cell carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Experience after 100 patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.A comparative analysis of postoperative pancreatic fistulas after surgery with and without hyperthermic intraperitoneal chemoperfusion.Pharmacokinetics of the perioperative use of cancer chemotherapy in peritoneal surface malignancy patientsDoes hyperthermic intraoperative chemotherapy lead to improved outcomes in patients with ovarian cancer? A single center cohort study in 111 consecutive patientsThe role of secondary surgery in recurrent ovarian cancer.Pulmonary Complications following Cytoreductive Surgery and Perioperative Chemotherapy in 147 Consecutive Patients.Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy.Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.Complications of Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal MetastasesHyperthermic Intraperitoneal Chemotherapy (HIPEC) Methodology, Drugs and Bidirectional ChemotherapyPeritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapyCytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma.Surgical biology for the clinician: peritoneal mesothelioma: current understanding and management.Traumatic implantation: a novel aetiology in the development of peritoneal mesothelioma.The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry.Systematic review on the efficacy of multimodal treatment of sarcomatosis with cytoreduction and intraperitoneal chemotherapy.The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma.Diffuse malignant peritoneal mesothelioma: systematic review of clinical management and biological research.Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: where are we?Assessment of clinical benefit and quality of life in patients undergoing cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for management of peritoneal metastasesIntraperitoneal chemotherapy: rationale, applications, and limitations.
P2860
Q26741293-F76F429C-A414-4BFB-BAEA-89033E89E23CQ26744031-36D7B3A9-4D8C-4F36-B59A-4CBC4E30B4C7Q26768296-267C2BAB-30CF-4AF5-BDF4-E7C409E9078DQ26768299-59DD0D29-BFCE-45EE-823E-F9C9F93D5952Q26768312-5535E4B0-58F2-44BA-ACC2-1445329B8A73Q26769938-EADC2729-EF12-467C-A09C-4B5D75C46557Q33394590-36946E5B-EEA9-45B9-864A-037F359C897EQ33416610-505042B2-0FE7-41DA-9F02-3B29651784FDQ33600938-9E331784-AE48-4E31-A453-C16B29BF3B09Q33909330-54809BA1-EC8E-4118-99D7-A7C2CBED689AQ34015030-8C217C06-611E-48D8-95A0-24BE001FEFBBQ34137322-D66BFAAB-6A4B-437E-B433-4697C85BBCFAQ34391061-33C349CF-BD8A-49E4-B927-DE085C1FDE18Q34391107-F9DFD9DA-A75F-44EE-A938-54B068A84FD5Q34917972-AAEC5B88-809E-4832-AB3C-04A895345FFAQ34996489-736F3322-02E2-4A5C-875E-6161E1BDE99BQ35687621-0CA34DD6-9224-48B8-9817-8F04A004398FQ35886383-D3313766-9E51-475D-975B-2B7F51D266D4Q35929166-27603554-D3D7-4D3F-9BAB-E3381EE2ECEFQ35955901-4AB6B7DE-2B49-46CC-B914-80460CC843AAQ36063487-8CADA396-E175-4C96-822D-66B74FBAADE3Q36125424-6368F820-AF18-441F-8D5D-7CDDAC1BBA35Q36167425-366F4E1B-D40A-4B57-8ECE-A4BB4424497CQ36181429-5C0476E5-7E5E-4C3E-88DE-7B849B1B52B2Q36444374-AD14CEBA-F031-4E87-AC09-9FF592C20147Q36611761-9A4CD406-0B3E-48F3-AF35-2B9187E2CAC9Q36758917-91C81742-7AA0-4AA8-B5BD-FA32266996D5Q36758933-7858E66F-47A3-47B7-8AFD-3F2216D3D2ECQ37090867-5CD21D1C-DE10-4AB4-A3B0-C76079181900Q37166451-AF2808B6-2315-4937-9005-A9D43C329ED1Q37398672-09A7F303-60A2-4245-8C37-362951487BBFQ37465788-E7CD5FEA-297A-43D7-8427-DD9B49B0FC9CQ37650823-EA3DFEB7-FA16-401E-BE43-8A046310D48EQ37779034-6F76A30D-F1BA-4959-8454-9D38349A961AQ37813173-221DB94F-F5F1-4B38-963D-5B2690EF71E2Q37833952-AB24385F-B8D7-4C1E-91E5-F5EE851FF756Q37993908-73FDC2F4-0B0E-473A-9692-3B087C42BC6DQ38053418-9F83D7F0-17D5-4E7D-AF8F-79F0C4CA1FDBQ38085569-C6DE65BF-22FD-497E-8DB4-CF5914C618B1Q38156120-F3A7A9BB-A1FD-40B2-9D7C-6BDA1A5F502C
P2860
A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A systematic review on the eff ...... nancy peritoneal mesothelioma.
@ast
A systematic review on the eff ...... nancy peritoneal mesothelioma.
@en
type
label
A systematic review on the eff ...... nancy peritoneal mesothelioma.
@ast
A systematic review on the eff ...... nancy peritoneal mesothelioma.
@en
prefLabel
A systematic review on the eff ...... nancy peritoneal mesothelioma.
@ast
A systematic review on the eff ...... nancy peritoneal mesothelioma.
@en
P2093
P2860
P356
P1433
P1476
A systematic review on the eff ...... nancy peritoneal mesothelioma.
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDL428
P577
2006-11-27T00:00:00Z